SkyCell announces sustainability report, commit for greener pharma supply chain
Switzerland based SkyCell, global pharma supply chain releases its first Sustainability Report. As part of their commitment towards a more sustainable future, the company’s mission is to be carbon neutral by 2040 and lead the way to a more sustainable pharma supply chain. The sustainability report is dedicated to the sustainability of our global operations and our initiatives for the planet and our stakeholders.
Since the company’s creation in 2012, SkyCell has held Environmental, Sustainability and Governance (ESG) at the core of its operations. To help combat climate change, SkyCell has committed in 2021, to the Paris Climate Agreement, in addition to having our emission targets approved by the Science-Based Targets initiative.
Richard Ettl, CEO and co-founder at Skycell, “Safeguarding our planet from the detrimental impact of climate change is not only important to me as a father, but I see it as the duty of any successful business."
This report comes at a time when action today is a necessity, within the industry and across the world. We are in conversations with the business partners and suppliers within the pharma supply to ensure we are all operating with a sustainable future in mind.
In an effort to help #MoveTheDate of Earth Overshoot Day, businesses around the world must endeavour to lower their company's footprint - which SkyCell is aiming to achieve throughout the supply chain with a multitude of targets outlined in our report.
0 comments:
Post a Comment